Summit Therapeutics Inc. (SMMT)
SMMT price $15.85 -0.24 -1.49%
- Ticker
- SMMT
- Price
- $15.85
- Change
- -0.24 -1.49%
- Market cap
- $12.64B
- P/E
- -14.37
- Forward P/E
- 180.04
- Sector
- Healthcare
- Industry
- Biotechnology
- Stocklytics score
- 70
Summit Therapeutics Inc. is a biopharmaceutical firm dedicated to discovering, developing, and commercializing therapeutic solutions, primarily targeting infectious diseases across the United States and Latin America. The company's clinical development pipeline is heavily concentrated on therapies for Clostridioides difficile infection (CDI). Its flagship product candidate, ridinilazole, is an orally administered…